Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial

Published:2015-04 Issue:9978 Volume:385 Page:1653-1661
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Ghanima Waleed,Khelif Abderrahim,Waage Anders,Michel Marc,Tjønnfjord Geir E,Romdhan Neila Ben,Kahrs Johannes,Darne Bernadette,Holme Pål Andrè

Publisher

Elsevier BV

Subject

General Medicine

Reference23 articles.

1. The ITP syndrome: pathogenic and clinical diversity;Cines;Blood,2009

2. International consensus report on the investigation and management of primary immune thrombocytopenia;Provan;Blood,2010

3. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia;Neunert;Blood,2011

4. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone;Cheng;N Engl J Med,2003

5. The course of severe autoimmune thrombocytopenia in patients not undergoing splenectomy;Sailer;Haematologica,2006

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematologic and lymphoid abnormalities in SLE;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. CAR-T cells for treating systemic lupus erythematosus: A promising emerging therapy;Joint Bone Spine;2024-09

3. A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia;New England Journal of Medicine;2024-06-20

4. Clinical efficacy of two different doses of rituximab as a treatment option in adult patients with chronic immune thrombocytopenia;The Egyptian Journal of Internal Medicine;2024-06-11

5. The Challenge for a Correct Diagnosis of Refractory Thrombocytopenia: ITP or MDS with Isolated Thrombocytopenia?;Cancers;2024-04-11